Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, December 5 2016 7:37pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > Upcoming Events
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
  
Recent Events for Biotechnology
View: Upcoming Events | Recent Events
Date Company Event
12/01/16 GNVC GenVec, Inc. 1-10 stock split
12/01/16 BLCM Bellicum Pharmaceuticals, Inc. coverage initiated by Raymond James
12/01/16 ITEK Inotek Pharmaceuticals Corporat coverage initiated by ROTH Capital
11/30/16 ASND Ascendis Pharma A/S - American downside earnings surprise (-17.65%)
11/30/16 ABUS Arbutus Biopharma Corporation upgraded by Chardan Capital Markets
11/30/16 ACOR Acorda Therapeutics, Inc. upgraded by JP Morgan
11/30/16 ARWR Arrowhead Pharmaceuticals, Inc. downgraded by William Blair
11/30/16 ARWR Arrowhead Pharmaceuticals, Inc. downgraded by Piper Jaffray
11/30/16 ARWR Arrowhead Pharmaceuticals, Inc. downgraded by Chardan Capital Markets
11/30/16 ARWR Arrowhead Pharmaceuticals, Inc. downgraded by Cantor Fitzgerald
11/30/16 BLCM Bellicum Pharmaceuticals, Inc. coverage initiated by Ladenburg Thalmann
11/29/16 CASC Cascadian Therapeutics, Inc. 1-6 stock split
11/29/16 FWP Forward Pharma A/S - American D upside earnings surprise (+34.29%)
11/29/16 ORPN Bioblast Pharma Ltd. - Ordinary downside earnings surprise (-27.27%)
11/29/16 NVLS Nivalis Therapeutics, Inc. downgraded by Stifel
11/29/16 NVLS Nivalis Therapeutics, Inc. downgraded by Robert W. Baird
11/29/16 NVLS Nivalis Therapeutics, Inc. downgraded by Raymond James
11/29/16 RVNC Revance Therapeutics, Inc. coverage initiated by Aegis Capital
11/28/16 IMMY Imprimis Pharmaceuticals, Inc. coverage initiated by Rodman & Renshaw
11/28/16 MDWD MediWound Ltd. - Ordinary Share coverage initiated by Aegis Capital
More Recent Events...
  


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?